Company Overview and News

 
NZ shares fall as investors cash in August gains; Tourism Holdings, A2 drop

2018-09-07 nzherald.co.nz
New Zealand shares fell for a third session, taking their weekly decline to 2.3 per cent, as investors cashed in some of August's gains in what was a strong month for the local market. Tourism Holdings and a2 Milk Co declined.
WYN AIR FCREY NZTCF RYM ACKDF ANZFY AUKNY AIZ KMD SKT SYKWF SKKTY KMD SML KTHDY AIA FBU RHCGF SPKKY NZTCY SPK FRCEF AIA FBU THL ANZLY RYHTY OHE ANZFF MEZ

 
NZ shares fall, led lower by Sky TV

2018-08-31 nzherald.co.nz
New Zealand shares dipped, led lower by Sky Network Television and Tourism Holdings, but gained over 4 per cent in the month after a busy earnings season.
TME TRMEF AIR FCREY RYM WHGPF ANZFY AIZ FTRRF CGF WHS SKT SYKWF WHOSY TME SKKTY SML FBU RHCGF THO FRCEF FBU THL ANZLY RYHTY ANZFF TDMEY

 
Brian Gaynor: Bull run ��� is it the 1980s all over again?

2018-08-24 nzherald.co.nz
Commentators are quick to point out that this is the longest bull market on record, stocks are overvalued and a crash is imminent.
CEN AIA FBU RHCGF FCREY AMP RYM ACKDF FRCEF AUKNY COENY COENF AIA FBU RYHTY CEN MEZ

 
Planned retirement villages will bring 320 jobs, $45m boost to Hawke's Bay, research shows

2018-08-19 nzherald.co.nz
With four new retirement villages in various stages of planning, new research suggests Hawke's Bay can expect a $45 million economic boost and more than 300 new jobs, if they all pan out.
RHCGF RYHTY RYM

 
Obituary: Gordon 'Tiger' Edmonds 19/11/25-28/7/18

2018-08-18 nzherald.co.nz
Gordon David "Tiger" Edmonds was larger than life in every single dimension, his nephew, Peter Edmonds, says.
RHCGF RYHTY RYM

 
NZ shares gain as investors take stock in earnings season

2018-08-17 nzherald.co.nz
New Zealand shares rose as investors took stock in a brief lull to the domestic corporate earnings season, with Skellerup Holdings extending yesterday's gain to break a new record.
CEN AIR NZTCF RYM ACKDF ANZFY AUKNY AIZ COENF GNE AOTUF SKC PPSHY CEN SNZ SKL GEL AIA RHCGF SPKKY NZTCY SPK COENY AIA THL ANZLY RYHTY SKLUY ANZFF GNE MEZ

 
Stock Takes: Is Apple still worth a bite?

2018-08-09 nzherald.co.nz
Technology stock Apple has become the world's first trillion-dollar public company but at US$207 ($310) a share does it still have more room to grow?
RHCGF ANZLY AIR RYHTY DTK ANZFF RYM ANZFY AIZ

 
SkyCity best performer as shares drop

2018-08-08 nzherald.co.nz
New Zealand shares fell, led lower by Pushpay Holdings' continued weakness, while SkyCity Entertainment Group gained on its strong annual results.
AIA FBU PYIYY RHCGF FCREY RYM ACKDF FRCEF AUKNY SKC AIA PPSHY FBU RYHTY PFI

 
NZ shares fall; Pushpay and Spark drop

2018-08-01 nzherald.co.nz
New Zealand shares fell as Pushpay Holdings hit a five-month low while Metlifecare and Spark New Zealand dropped.
RHCGF PPSHY NZTCY SPKKY RYHTY SPK GTK NZTCF RYM

2
Ryman Healthcare (RYHTY) Investor Presentation - Slideshow

2018-07-26 seekingalpha - 2
The following slide deck was published by Ryman Healthcare Ltd. ADR in conjunction with this event.
RHCGF RYHTY RYM

3
NZ shares dip as Facebook woes colour global markets

2018-07-26 nzherald.co.nz - 1
New Zealand shares edged lower as a weak earnings result from Facebook cast a pall over global equity markets while investors prepare for the local earnings season. Property For Industry and Heartland Bank declined, while Sky Network Television extended its recovery.
CEN FB PYIYY AIR FCREY NZTCF RYM ACKDF ANZFY AUKNY AIZ COENF SKT SYKWF CEN SKKTY AIA FBU RHCGF SPKKY NZTCY SPK FRCEF COENY AIA FBU ANZLY RYHTY ANZFF MEZ PFI

1
NZ shares up, led by Fisher & Paykel Healthcare, Ryman

2018-07-20 nzherald.co.nz - 1
New Zealand shares gained, turning around from recent weakness, with Fisher & Paykel Healthcare Corp and Ryman Healthcare leading stocks higher.
RHCGF PPSHY RYHTY RYM

 
NZ shares drop on Z Energy downgrade

2018-07-18 nzherald.co.nz
New Zealand shares fell, led by Z Energy following an earnings downgrade, with Ryman Healthcare and NZX also declining.
KTHDY PGC ZNZ RHCGF RYHTY ZNRGF GTK RYM ZEL KMD KMD

 
MARKET WRAP: NZ shares fall, tech stocks gain

2018-07-16 nbr.co.nz
New Zealand shares fell below the 9000 mark today, despite a solid trading day for technology stocks and for retailer Kathmandu.
ZNZ RHCGF RYHTY ZNRGF RYM NZR ZEL

1
Brian Gaynor: KiwiSavers should surf wave of cash

2018-07-13 nzherald.co.nz - 1
The world is awash with cash, and private equity (PE) funds are a clear example of this phenomenon.
IQE RHCGF IQE MPP RYHTY MTPGF RYM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 006161525